ATE359358T1 - Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden - Google Patents

Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden

Info

Publication number: ATE359358T1
Authority: AT; Austria
Prior art keywords: cells; media; sialylysis; controlling; proteins produced
Prior art date: 2002-07-15

Application number

AT03764511T

Other languages

English (en)

Inventor

Brian D Follstad

Original Assignee

Immunex Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-15

Filing date

2003-07-14

Publication date

2007-05-15

2003-07-14 Application filed by Immunex Corp filed Critical Immunex Corp

2007-05-15 Application granted granted Critical

2007-05-15 Publication of ATE359358T1 publication Critical patent/ATE359358T1/de

Links

238000000034 method Methods 0.000 title abstract 4
102000004169 proteins and genes Human genes 0.000 title abstract 3
108090000623 proteins and genes Proteins 0.000 title abstract 3
241000124008 Mammalia Species 0.000 title 1
210000004027 cell Anatomy 0.000 abstract 4
238000012258 culturing Methods 0.000 abstract 3
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 2
229930091371 Fructose Natural products 0.000 abstract 2
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 2
239000005715 Fructose Substances 0.000 abstract 2
OVRNDRQMDRJTHS-OZRXBMAMSA-N N-acetyl-beta-D-mannosamine Chemical compound CC(=O)N[C@@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-OZRXBMAMSA-N 0.000 abstract 2
229930182830 galactose Natural products 0.000 abstract 2
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract 1
210000004962 mammalian cell Anatomy 0.000 abstract 1
230000009450 sialylation Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins

Landscapes

Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

AT03764511T 2002-07-15 2003-07-14 Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden ATE359358T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US39622102P	2002-07-15	2002-07-15

Publications (1)

Publication Number	Publication Date
ATE359358T1 true ATE359358T1 (de)	2007-05-15

Family

ID=30115987

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03764511T ATE359358T1 (de)	2002-07-15	2003-07-14	Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden

Country Status (15)

Country	Link
US (1)	US7645609B2 (de)
EP (1)	EP1543106B1 (de)
JP (1)	JP4510938B2 (de)
AT (1)	ATE359358T1 (de)
AU (1)	AU2003249055B2 (de)
CA (1)	CA2492267C (de)
CY (1)	CY1107689T1 (de)
DE (1)	DE60313188T2 (de)
DK (1)	DK1543106T3 (de)
ES (1)	ES2285188T3 (de)
MX (1)	MXPA05000552A (de)
PL (1)	PL376381A1 (de)
PT (1)	PT1543106E (de)
SI (1)	SI1543106T1 (de)
WO (1)	WO2004008100A2 (de)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7332303B2 (en) †	2002-12-23	2008-02-19	Bristol-Myers Squibb Company	Product quality enhancement in mammalian cell culture processes for protein production
US8052667B2 (en) *	2004-09-07	2011-11-08	Velico Medical, Inc.	Apparatus for prolonging survival of platelets
AU2005295467B2 (en) *	2004-10-15	2011-07-07	Velico Medical, Inc.	Compositions and methods for prolonging survival of platelets
ES2336832T3 (es)	2005-07-22	2010-04-16	Five Prime Therapeutics, Inc.	Composiciones y procedimientos para tratar enfermedades con proteinas de fusion de fgfr.
EP1937306B1 (de) *	2005-08-19	2016-02-17	Janssen Biotech, Inc.	Proteolyse-resistente antikörperzubereitungen
EP1954304A4 (de) *	2005-10-14	2010-03-10	Zymequest Inc	Zusammensetzungen und verfahren zur verlängerung der lebensdauer von plättchen
AR058568A1 (es)	2005-12-20	2008-02-13	Bristol Myers Squibb Co	Metodos para producir una composicion con moleculas ctla4-ig a partir de un medio de cultivo
PL2253644T3 (pl) *	2005-12-20	2014-04-30	Bristol Myers Squibb Co	Kompozycje i sposoby wytwarzania kompozycji
KR101495549B1 (ko)	2006-07-13	2015-02-25	와이어쓰 엘엘씨	당단백질의 생산
MX353340B (es)	2006-09-13	2018-01-09	Abbvie Inc	Mejoras de cultivos celulares.
US8911964B2 (en)	2006-09-13	2014-12-16	Abbvie Inc.	Fed-batch method of making human anti-TNF-alpha antibody
EP2120998B1 (de)	2006-11-28	2013-08-07	HanAll Biopharma Co., Ltd.	Modifizierte erythropoetin-polypeptide und ihre verwendungen zur behandlung
WO2008120570A1 (ja) *	2007-03-19	2008-10-09	National University Corporation Okayama University	タンパク質産生用およびウイルス増殖用の培地
TW200902708A (en)	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
CN102171343B (zh)	2008-08-04	2017-07-14	戊瑞治疗有限公司	Fgfr细胞外结构域酸性区突变蛋白
SG195577A1 (en)	2008-10-20	2013-12-30	Abbott Lab	Viral inactivation during purification of antibodies
TW201024318A (en)	2008-10-20	2010-07-01	Abbott Lab	Isolation and purification of antibodies using protein A affinity chromatography
EP2233502A1 (de) *	2009-03-27	2010-09-29	Deutsches Rheuma-Forschungszentrum Berlin	Sialylierte antigenspezifische Antikörper zur Behandlung oder Vorbeugung von ungewollten entzündlichen Immunreaktionen und Verfahren zu deren Herstellung
EP2478003A4 (de)	2009-09-15	2013-05-29	Five Prime Therapeutics Inc	Haarwuchsverfahren unter verwendung extrazellulärer fgfr4-domänen
CA2780457A1 (en)	2009-11-13	2011-05-19	Five Prime Therapeutics, Inc.	Use of fgfr1 extra cellular domain proteins to treat cancers characterized by ligand-dependent activating mutations in fgfr2
KR101808751B1 (ko)	2009-11-13	2017-12-13	그리폴스 테라퓨틱스 인코포레이티드	폰 빌레브란트 인자(ｖＷＦ)-함유 제제, 및 그와 관련된 방법, 키트 및 용도
EP2325296A1 (de)	2009-11-20	2011-05-25	LEK Pharmaceuticals d.d.	Herstellung von Glykoproteinen mit niedrigem N-Glykolylneuraminsäure-Gehalt (Neu5Gc-Gehalt)
EP2512501A4 (de)	2009-12-17	2014-01-01	Five Prime Therapeutics Inc	Haarwuchsverfahren unter verwendung extrazellulärer fgfr3-domänen
PT2563904E (pt)	2010-04-26	2015-05-12	Novartis Ag	Meio de cultura de células aperfeiçoado
US8481038B2 (en)	2010-11-15	2013-07-09	Five Prime Therapeutics, Inc.	Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins
US8951972B2 (en)	2010-12-09	2015-02-10	Five Prime Therapeutics, Inc.	FGFR1 extracellular domain combination therapies for lung cancer
US9062106B2 (en)	2011-04-27	2015-06-23	Abbvie Inc.	Methods for controlling the galactosylation profile of recombinantly-expressed proteins
JP6280499B2 (ja) *	2011-07-08	2018-02-14	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	Ｆｃ融合タンパク質の精製方法
CA2855818A1 (en)	2011-11-14	2013-05-23	Five Prime Therapeutics, Inc.	A method of treating lung cancer having an fgfr1 gene amplification or fgfr1 overexpression
WO2013158273A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en)	2013-03-14	2015-06-30	Abbvie, Inc.	Protein purification using displacement chromatography
WO2013158279A1 (en)	2012-04-20	2013-10-24	Abbvie Inc.	Protein purification methods to reduce acidic species
US9249182B2 (en)	2012-05-24	2016-02-02	Abbvie, Inc.	Purification of antibodies using hydrophobic interaction chromatography
KR20150043523A (ko)	2012-09-02	2015-04-22	애브비 인코포레이티드	단백질 불균일성의 제어 방법
US9512214B2 (en)	2012-09-02	2016-12-06	Abbvie, Inc.	Methods to control protein heterogeneity
US20140106405A1 (en) *	2012-10-15	2014-04-17	Bristol-Myers Squibb Company	Mammalian cell culture processes for protein production
SG11201507230PA (en)	2013-03-12	2015-10-29	Abbvie Inc	Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) *	2013-03-14	2014-09-25	Abbvie Inc.	Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en)	2013-10-18	2015-04-28	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same using displacement chromatography
TWI625390B (zh) *	2013-03-14	2018-06-01	安美基公司	用於增加重組蛋白質之甘露糖含量之方法
US8956830B2 (en)	2013-03-14	2015-02-17	Momenta Pharmaceuticals, Inc.	Methods of cell culture
US8921526B2 (en)	2013-03-14	2014-12-30	Abbvie, Inc.	Mutated anti-TNFα antibodies and methods of their use
SG11201507875RA (en) *	2013-03-26	2015-10-29	Coherus Biosciences Inc	Protein production method
US9481901B2 (en) *	2013-05-30	2016-11-01	Amgen Inc.	Methods for increasing mannose content of recombinant proteins
EP3052640A2 (de)	2013-10-04	2016-08-10	AbbVie Inc.	Verwendung von metallionen zur modulation von proteinglykosylierungsprofilen rekombinanter proteine
US8946395B1 (en)	2013-10-18	2015-02-03	Abbvie Inc.	Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en)	2013-10-18	2015-11-10	Abbvie, Inc.	Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en)	2013-10-18	2015-07-21	Abbvie, Inc.	Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en)	2013-11-15	2015-05-21	Abbvie, Inc.	Glycoengineered binding protein compositions
CN106102749B (zh) *	2014-03-05	2019-07-12	奥特吉尼克斯制药公司	唾液酸化糖蛋白组合物及其用途
JP6652334B2 (ja) *	2014-05-31	2020-02-19	Ｊｃｒファーマ株式会社	ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地
US20160130324A1 (en)	2014-10-31	2016-05-12	Shire Human Genetic Therapies, Inc.	C1 Inhibitor Fusion Proteins and Uses Thereof
WO2017087882A1 (en)	2015-11-19	2017-05-26	Shire Human Genetic Therapies, Inc.	Recombinant human c1 esterase inhibitor and uses thereof
IL321253A (en)	2018-05-01	2025-08-01	Amgen Inc	Antibodies with a modulated glycan profile
HUE071524T2 (hu)	2018-07-03	2025-09-28	Gilead Sciences Inc	HIV GP120-at célzó antitestek és alkalmazási eljárások
CN113748129A (zh)	2018-12-21	2021-12-03	杭州景杰生物科技股份有限公司	蛋白质赖氨酸乳酸酰化检测试剂和方法
JP2024503239A (ja)	2020-12-22	2024-01-25	アムジェンインコーポレイテッド	細胞培養法
EP4301333A2 (de)	2021-03-03	2024-01-10	Formycon AG	Formulierungen von ace2-fc-fusionsproteinen
WO2023094507A1 (en)	2021-11-24	2023-06-01	Formycon Ag	Improved ace2 fusion proteins
CN114317446B (zh) *	2021-12-30	2023-12-05	广州康盛生物科技股份有限公司	一种无血清培养基用添加剂及其应用
EP4331571A1 (de)	2022-09-02	2024-03-06	Formycon AG	Formulierungen von ace2-igm-fusionsproteinen
EP4386084A1 (de)	2022-12-14	2024-06-19	Formycon AG	Verbesserte ace2-fusionsproteine
TW202521562A (zh)	2023-08-11	2025-06-01	美商默沙東有限責任公司	單價介白素-12(IL-12) 異二聚體Fc蛋白

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5672502A (en) *	1985-06-28	1997-09-30	Celltech Therapeutics Limited	Animal cell culture
US5047335A (en) *	1988-12-21	1991-09-10	The Regents Of The University Of Calif.	Process for controlling intracellular glycosylation of proteins
JP3375140B2 (ja)	1991-03-08	2003-02-10	森永製菓株式会社	モノクローナル抗体生産用培地の作製法及びそのキット
WO1993022448A1 (en) *	1992-05-01	1993-11-11	Teijin Limited	Fed batch culture method for protein secreting cells
JPH06292592A (ja) *	1993-02-09	1994-10-21	Snow Brand Milk Prod Co Ltd	糖蛋白質の生産方法
US5858783A (en) *	1993-05-25	1999-01-12	The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration	Production of normal mammalian organ culture using a medium containing mem-alpha, leibovitz L-15, glucose galactose fructose
EP1659173A1 (de) *	1997-10-01	2006-05-24	DSMIP Assets B.V.	Verfahren zur Protein-Herstellung
ATE309350T1 (de) *	1997-12-03	2005-11-15	Roche Diagnostics Gmbh	Verfahren zur herstellung von polypeptiden mit geeigneter glykosilierung
TR200001580T2 (tr)	1997-12-03	2000-12-21	Roche Diagnostics Gmbh	Spesifik etkinliği yüksek eritropoyetin
WO2000007602A1 (en) *	1998-08-06	2000-02-17	The Johns Hopkins University School Of Medicine	Compounds for altering cell surface sialic acids and methods of use therefor
DE19852729A1 (de)	1998-11-16	2000-05-18	Werner Reutter	Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
US6949372B2 (en) *	1999-03-02	2005-09-27	The Johns Hopkins University	Engineering intracellular sialylation pathways
US6261805B1 (en) *	1999-07-15	2001-07-17	Boyce Thompson Institute For Plant Research, Inc.	Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
EP1298217A4 (de) *	2000-07-05	2004-09-08	Mitsubishi Pharma Corp	Verfahren zur Herstellung eines Glykoproteins
US20040214228A9 (en) *	2001-09-14	2004-10-28	Ganesh Venkataraman	Methods of evaluating glycomolecules for enhanced activities
JP4281797B2 (ja)	2006-12-21	2009-06-17	三菱自動車工業株式会社	車両の車体構造

2003
- 2003-07-14 WO PCT/US2003/021733 patent/WO2004008100A2/en not_active Ceased
- 2003-07-14 DE DE60313188T patent/DE60313188T2/de not_active Expired - Lifetime
- 2003-07-14 ES ES03764511T patent/ES2285188T3/es not_active Expired - Lifetime
- 2003-07-14 AU AU2003249055A patent/AU2003249055B2/en not_active Expired
- 2003-07-14 AT AT03764511T patent/ATE359358T1/de not_active IP Right Cessation
- 2003-07-14 EP EP03764511A patent/EP1543106B1/de not_active Expired - Lifetime
- 2003-07-14 MX MXPA05000552A patent/MXPA05000552A/es active IP Right Grant
- 2003-07-14 SI SI200330783T patent/SI1543106T1/sl unknown
- 2003-07-14 CA CA2492267A patent/CA2492267C/en not_active Expired - Lifetime
- 2003-07-14 JP JP2004521682A patent/JP4510938B2/ja not_active Expired - Lifetime
- 2003-07-14 PT PT03764511T patent/PT1543106E/pt unknown
- 2003-07-14 DK DK03764511T patent/DK1543106T3/da active
- 2003-07-14 PL PL03376381A patent/PL376381A1/xx not_active Application Discontinuation
- 2003-07-15 US US10/620,064 patent/US7645609B2/en not_active Expired - Lifetime
2007
- 2007-07-02 CY CY20071100866T patent/CY1107689T1/el unknown

Also Published As

Publication number	Publication date
DE60313188T2 (de)	2007-12-20
US20040115768A1 (en)	2004-06-17
DK1543106T3 (da)	2007-08-13
ES2285188T3 (es)	2007-11-16
SI1543106T1 (sl)	2007-08-31
CA2492267C (en)	2013-09-10
PL376381A1 (en)	2005-12-27
CA2492267A1 (en)	2004-01-22
WO2004008100A3 (en)	2004-03-25
AU2003249055A1 (en)	2004-02-02
MXPA05000552A (es)	2005-04-28
CY1107689T1 (el)	2013-04-18
JP4510938B2 (ja)	2010-07-28
WO2004008100A2 (en)	2004-01-22
US7645609B2 (en)	2010-01-12
JP2005532813A (ja)	2005-11-04
DE60313188D1 (de)	2007-05-24
EP1543106A2 (de)	2005-06-22
EP1543106B1 (de)	2007-04-11
EP1543106A4 (de)	2005-08-10
AU2003249055B2 (en)	2008-06-26
PT1543106E (pt)	2007-05-31

Legal Events

Date

Code

Title

Description

2007-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1543106

Country of ref document: EP

2011-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60313188D1 (de)	2007-05-24	Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden
EP1360314A4 (de)	2004-08-11	Chemisch definiertes medium für kultivierte säugerzellen
DE69939901D1 (de)	2008-12-24	Verfahren und materialien zur herstellung von glucosamin
ATE405644T1 (de)	2008-09-15	Verfahren zur herstellung und reinigung von erythropoietin
BR0311413A (pt)	2005-03-22	Desenvolvimento e transdiferenciação de células acinares humanas
DE502004008542D1 (de)	2009-01-08	Verfahren zur reklonierung von produktionszellen
NO973801L (no)	1997-10-20	Nye proteiner og fremgangsmåter for fremstilling av proteinene
ATE406435T1 (de)	2008-09-15	Methoden zur züchtung von tierzellen
ATE430807T1 (de)	2009-05-15	Verfahren zur kultivierung von circovirus
ATE553187T1 (de)	2012-04-15	Konditioniertes zellkulturmedium, verfahren zur herstellung und dessen verwendung zur haltung, proliferation und differenzierung von säugetierzellen
ATE517996T1 (de)	2011-08-15	Verfahren und mittel zur erhöhung der toleranz von pflanzen gegenüber stressbedingungen
DE69534227D1 (de)	2005-06-30	Stoffe und verfahren zur beherrschung der hyperakuten abstossung von menschlichen transplantaten
WO2004090096A3 (en)	2005-03-03	Methods for neural differentiation of embryonic stem cells using protease passaging techniques
ATE426674T1 (de)	2009-04-15	Stoffwechselanderungen in garungen zur produktion rekombinanter proteine
DE60041821D1 (de)	2009-04-30	Pluripotent embryonale stammzellen-ähnliche zellen, zusammensetzungen und ihre vervendungen
ATE279441T1 (de)	2004-10-15	Verfahren zur herstellung von genetisch veränderten lymphozyten vorläuferzellen von wirbeltieren und deren gebrauch zur produktion von heterologen bindeproteinen
ATE330003T1 (de)	2006-07-15	Rekombinanter stabiler zellklon, seine herstellung und verwendung
BR0014519A (pt)	2002-06-11	Sequências de sinais para a preparação de leu-herudin através da secreção por e. coli no meio de cultura
DE60211772D1 (de)	2006-07-06	Verfahren zur Herstellung von Proteine
ATE486944T1 (de)	2010-11-15	Translationselongationsfaktor-promotor aus pichia pastoris und verfahren zur herstellung von rekombinantem protein unter verwendung davon
ATE517176T1 (de)	2011-08-15	Verfahren zur kultivierung von geschmackszellen aus säugern
EA200100023A1 (ru)	2001-06-25	Промышленный способ производства гетерологичных белков в пригодных для этого способа штаммах е.coli
ATE201908T1 (de)	2001-06-15	Verfahren zur herstellung von riboflavin mittels mikroorganismen mit veränderter isocitratlyase- aktivität
RU2018130530A (ru)	2020-04-17	Способ получения активного фактора роста гепатоцитов (hgf)
ATE378397T1 (de)	2007-11-15	Verfahren zum kultivieren von mikroorganismen unter reduzierenden bedingungen mittels einer gasströmung